Similar articles

• Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents.

  Ramanath VS, Brown JR, Malenka DJ, DeVries JT, Sidhu MS, Robb JF, Jayne JE, Hettleman BD, Friedman BJ, Niles NW 2nd, Kaplan AV, Thompson CA; Dartmouth Dynamic Registry Investigators. Ramanath VS, et al. Catheter Cardiovasc Interv. 2010 Oct 1;76(4):473-81. doi: 10.1002/ccd.22512. Catheter Cardiovasc Interv. 2010. PMID: 20882647
• A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort.

  Bental T, Assali A, Vaknin-Assa H, Lev EI, Brosh D, Fuchs S, Battler A, Kornowski R. Bental T, et al. Catheter Cardiovasc Interv. 2010 Sep 1;76(3):374-80. doi: 10.1002/ccd.22507. Catheter Cardiovasc Interv. 2010. PMID: 20839351
• DES in SVGs: safe and at least short-term effective.

  Hillegass WB. Hillegass WB. Catheter Cardiovasc Interv. 2011 Feb 15;77(3):356-7. doi: 10.1002/ccd.22972. Catheter Cardiovasc Interv. 2011. PMID: 21328680 No abstract available.
• Is there a need for dedicated bifurcation devices?

  Lefèvre T, Chevalier B, Louvard Y. Lefèvre T, et al. EuroIntervention. 2010 Dec;6 Suppl J:J123-9. doi: 10.4244/EIJV6SUPJA20. EuroIntervention. 2010. PMID: 21930476 Review. No abstract available.
• Provisional side branch stenting for the treatment of bifurcation lesions.

  Lefèvre T, Darremont O, Albiero R. Lefèvre T, et al. EuroIntervention. 2010 Dec;6 Suppl J:J65-71. doi: 10.4244/EIJV6SUPJA11. EuroIntervention. 2010. PMID: 21930493 Review. No abstract available.